Dr Emmanouil Pyrgiotakis
-
Email
e.pyrgiotakis@essex.ac.uk -
Telephone
+44 (0) 1206 874463
-
Location
EBS.3.88, Colchester Campus
Research and professional activities
Research interests
Corporate Finance
Mergers and Acquisitions
Initial Public Offerings
Textual Analysis
Teaching and supervision
Current teaching responsibilities
-
Portfolio Analysis (BE313)
-
Risk Management (BE361)
-
Risk Management and Financial Institutions (BE631)
Current supervision
Publications
Journal articles (7)
Katsafados, AG., Leledakis, GN., Pyrgiotakis, EG., Androutsopoulos, I. and Fergadiotis, M., (2024). Machine learning in bank merger prediction: A text-based approach. European Journal of Operational Research. 312 (2), 783-797
Pyrgiotakis, E., Leledakis, G., Gkoumas, N. and Androutsopoulos, I., (2024). Bank Competition, Loan PortfolioConcentration and Stock Price Crash Risk: TheRole of Tone Ambiguity. British Journal of Management
Makrychoriti, P. and Pyrgiotakis, EG., (2024). Firm-level political risk and stock price crashes. Journal of Financial Stability. 74, 101303-101303
Gaganis, C., Leledakis, G., Pasiouras, F. and Pyrgiotakis, E., (2024). National culture of secrecy and stock price synchronicity: cross-country evidence. Journal of Banking & Finance, 107341-107341
Drousia, A., Episcopos, A., Leledakis, GN. and Pyrgiotakis, EG., (2023). EU Regulation and open market share repurchases: new evidence. The European Journal of Finance. 29 (9), 1022-1042
Leledakis, GN. and Pyrgiotakis, EG., (2022). U.S. bank M&As in the post-Dodd–Frank Act era: Do they create value?. Journal of Banking & Finance. Online, 105576-105576
Leledakis, G., Mamatzakis, E., Pyrgiotakis, E. and Travlos, N., (2020). Does it pay to acquire private firms? Evidence from the U.S. banking industry. The European Journal of Finance. 27 (10), 1029-1051
Reports and Papers (1)
Kontonikas, A. and Pyrgiotakis, E., (2024). A comprehensive analysis of transactions in the Greek residential property market
Grants and funding
2024
Modelling Greek Firms� Survival Rates and Identifying 'Zombies'
PricewaterhouseCoopers
